A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-02-23
DOI
10.3389/fimmu.2017.00100
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis
- (2017) C. Patrick McAtee et al. PROTEIN EXPRESSION AND PURIFICATION
- Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis
- (2017) Micheli Luize Barbosa Santos et al. Frontiers in Immunology
- Heterogeneity, functional specialization and differentiation of monocyte-derived dendritic cells
- (2016) Kevin V Chow et al. IMMUNOLOGY AND CELL BIOLOGY
- Field randomized trial to evaluate the efficacy of the Leish-Tec ® vaccine against canine visceral leishmaniasis in an endemic area of Brazil
- (2016) Shara Regina-Silva et al. VACCINE
- Expression and purification of an engineered, yeast-expressedLeishmania donovaninucleoside hydrolase with immunogenic properties
- (2016) Elissa M. Hudspeth et al. Human Vaccines & Immunotherapeutics
- Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate
- (2016) Jairo E. Perez-Franco et al. PLoS Neglected Tropical Diseases
- Post-Genomics and Vaccine Improvement for Leishmania
- (2016) Negar Seyed et al. Frontiers in Microbiology
- An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene
- (2016) Zhiwu Sun et al. Emerging Microbes & Infections
- IFN-γ-Dependent Recruitment of CD4+T Cells and Macrophages Contributes to Pathogenesis DuringLeishmania amazonensisInfection
- (2015) Matheus Batista Heitor Carneiro et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice
- (2015) Haniyeh Ghaffari-Nazari et al. PLoS One
- Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways
- (2015) Carol S. K. Leung Frontiers in Immunology
- Arginase I, Polyamine, and Prostaglandin E2Pathways Suppress the Inflammatory Response and Contribute to Diffuse Cutaneous Leishmaniasis
- (2014) Jaqueline França-Costa et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
- (2014) Negar Seyed et al. PLoS One
- Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains
- (2014) Dirlei Nico et al. Frontiers in Immunology
- Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection
- (2014) Dirlei Nico et al. Frontiers in Immunology
- Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives
- (2012) Ana Paula Fernandes et al. CURRENT OPINION IN MICROBIOLOGY
- Induction of Protective CD4+ T Cell-Mediated Immunity by a Leishmania Peptide Delivered in Recombinant Influenza Viruses
- (2012) Katherine Kedzierska et al. PLoS One
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Improved Canine and Human Visceral Leishmaniasis Immunodiagnosis Using Combinations of Synthetic Peptides in Enzyme-Linked Immunosorbent Assay
- (2012) Míriam Maria Costa et al. PLoS Neglected Tropical Diseases
- Visceral leishmaniasis: immunology and prospects for a vaccine
- (2011) P.M. Kaye et al. CLINICAL MICROBIOLOGY AND INFECTION
- Adaptive Immunity against Leishmania Nucleoside Hydrolase Maps Its C-Terminal Domain as the Target of the CD4+ T Cell–Driven Protective Response
- (2010) Dirlei Nico et al. PLoS Neglected Tropical Diseases
- Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors
- (2009) Wim Versées et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Immunopathogenic competences ofLeishmania(V.)braziliensisandL.(L.)amazonensisin American cutaneous leishmaniasis
- (2009) F. T. SILVEIRA et al. PARASITE IMMUNOLOGY
- Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune® in Brazilian endemic areas
- (2009) Clarisa B. Palatnik-de-Sousa et al. VACCINE
- Structural Basis for Substrate Specificity in Group I Nucleoside Hydrolases†,‡
- (2008) Elena Iovane et al. BIOCHEMISTRY
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
- (2008) Clarisa B Palatnik-de-Sousa et al. Expert Review of Vaccines
- Vaccines for leishmaniasis in the fore coming 25 years
- (2008) Clarisa B. Palatnik-de-Sousa VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search